In This Section

Program

Wednesday, September 24 

Thursday, September 25 

Friday, September 26 

Saturday, September 27 

Wednesday, September 24

REGISTRATION

3-7 p.m.

WELCOME AND Keynote Lecture

6-6:50 p.m. 

Reception 

7-9 p.m. 

Thursday, September 25

Keynote Address 

8-8:50 a.m.

  • Introduction of Keynote Speaker
  • Autoimmunity and Cancer: Informing Each Other through Patient-Oriented Studies  
    Virginia Pascual, Weill Cornell Medical College, New York, New York

Plenary Session 1: Immune Tolerance and Surveillance: Implications for Cancer and Autoimmunity

8:55-10:45 a.m.

  • Dissecting Immune Tolerance Through Outliers 
    Mark Anderson, University of California, San Francisco, California 

Additional speakers to be announced

Short talks selected from proffered abstracts

Break 

10:45-11:05 a.m. 

Plenary Session 2: Innate Sensing and Type I Interferon Response in Cancer and Autoimmune Disease 

11:05 am-12:55 p.m.

  • Sandra Demaria, Weill Cornell Medicine, New York, New York
  • Targeting Inflammatory Memory and Chronic Interferon Signaling in Cancer Immunotherapy 
    Andy J. Minn, University of Pennsylvania, Philadelphia, Pennsylvania
  • A Genome-Wide Look at Tumor Immunoediting  
    Judy Lieberman, Harvard Medical School, Boston, Massachusetts

Short talks selected from proffered abstracts

Free time / Lunch on your own 

12:55-2:55 p.m. 

Plenary Session 3: Epigenetic and Genetic Regulation of Cancer Immunity and Autoimmunity  

2:55-4:45 p.m. 

  • Kunle Odunsi, University of Chicago Medicine Comprehensive Cancer Center, Chicago, IL 
  • Epigenetic Regulation of T cells in Autoimmunity and Anti-Cancer Immunity
    Maureen Su, UCSF – University of California San Francisco, California

Additional speakers to be announced

Short talks selected from proffered abstracts

Break 

4:45-5 p.m.

Session to be announced

5-6 p.m.

Poster Session A and Reception 

6:15-8:15 p.m.

Friday, September 26

 

Continental Breakfast and Networking Roundtables

7-8 a.m.

Plenary Session 4: Therapeutics at the Intersection of Cancer and Autoimmunity 

8-9:50 a.m.

Speakers to be announced

Break 

9:50- 10:10 a.m.

Plenary Session 5: Role of Microbiota in Immunologic Fitness  

10:10 a.m. – 12 p.m.

  • Laurence Zitvogel, Goustave Roussy, Paris, France   

Additional speakers to be announced

Short talks selected from proffered abstracts

Free time / Lunch on your own 

12 – 2 p.m.

Plenary Session 6: CD8 T cells in Cancer and Autoimmunity 

2-3:50 p.m. 

  • Ana C. Anderson, Harvard Medical School and Brigham and Women’s Hospital, Boston, Massachusetts
  • E. John Wherry, University of Pennsylvania, Philadelphia, Pennsylvania 
  • T Cell Stemness and Differentiation in Autoimmunity and Cancer  
    Andrea Schietinger, Memorial Sloan-Kettering Cancer Center, New York, New York 

Short talks selected from proffered abstracts

Break 

3:50 -4:10 p.m.

Plenary Session 7: Interplay of B and T cells in Cancer and Autoimmunity 

4:10-6 p.m. 

  • Modulating B and T Cell Interactions Within and Outside of Tertiary Lymphoid Structures for Improved Anti-Tumor Immunity  
    Tullia Bruno, University of Pittsburgh, Pittsburgh, Pennsylvania 
  • Ignacio Sanz, Emory University, Atlanta, Georgia 

Additional speakers to be announced

Short talks selected from proffered abstracts

Poster Session B and Reception 

6:15-8:15 p.m. 

Saturday, September 27

Continental Breakfast and Networking Roundtables

7-8 a.m.

Panel Discussion: Modeling immune-related adverse events 

8-8:45 a.m.

Plenary Session 8: Targeting Regulatory T cells in the Tumor Microenvironment and in Autoimmunity  

8:50-10:40 a.m. 

  • From Concept to Cure: Developing TregSight for Precision Immunotherapy 
    Billur Akkaya, Ohio State University, Columbus, Ohio 
  • Dario AA Vignali, University of Pittsburgh, Pittsburgh, Pennsylvania
  • CAR-Treg Adoptive Immunotherapy to Treat Autoimmune Disease
    Jeff Bluestone, University of California, San Francisco, California 

Additional speakers to be announced

Short talks selected from proffered abstracts

Plenary Session 9: Activity and Autoimmune Toxicity of Cancer Immunotherapy  

10:55 a.m.-12:45 p.m. 

  • Predicting, Monitoring, and Diagnosing Immune-Related Adverse Events
    David E. Gerber, University of Texas Southwestern Medical Center, Dallas, Texas 
  • Chloe Villani, Massachusetts General Hospital (MGH) Center for Cancer Research, Boston, Massachusetts

Additional speakers to be announced

Short talks selected from proffered abstracts